Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center
|
September 27, 2022
Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
Caroline Hamm, Dora Cavallo-Medved, Devinder Moudgil, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study
Michael D Prados, W K A Yung, Patrick Y Wen, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
Elaine T Lam, Cindy L O'Bryant, Michele Basche, et al.
Journal of the National Cancer Institute
|
December 14, 2018
Current Activities of the Coalition of Cancer Cooperative Groups
Monica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2007
Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors
Antonio Jimeno, Michelle A Rudek, Thomas Purcell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer
Changhu Chen, Madeleine Kane, John Song, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 2009
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas
Shivaani Kummar, Martin E Gutierrez, Erin R Gardner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2023
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Frances A Shepherd, Janet Dancey, Rodryg Ramlau, et al.
Cancer Chemotherapy and Pharmacology
|
May 22, 2010
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)
Eric H Kraut, Christopher Rhoades, Yilong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study
Lillian L Siu, Denis Soulieres, Eric X Chen, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Cancer Control : Journal of the Moffitt Cancer Center
|
September 27, 2022
Addressing the Barriers to Clinical Trials Accrual in Community Cancer Centres Using a National Clinical Trials Navigator:A Cross-Sectional Analysis
Caroline Hamm, Dora Cavallo-Medved, Devinder Moudgil, et al.
Cancer Chemotherapy and Pharmacology
|
August 19, 2007
Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study
Michael D Prados, W K A Yung, Patrick Y Wen, et al.
Molecular Cancer Therapeutics
|
December 17, 2008
A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
Elaine T Lam, Cindy L O'Bryant, Michele Basche, et al.
Journal of the National Cancer Institute
|
December 14, 2018
Current Activities of the Coalition of Cancer Cooperative Groups
Monica M Bertagnolli, Susan M Blaney, Charles D Blanke, et al.
Cancer Chemotherapy and Pharmacology
|
April 13, 2007
Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors
Antonio Jimeno, Michelle A Rudek, Thomas Purcell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2007
Phase I trial of gefitinib in combination with radiation or chemoradiation for patients with locally advanced squamous cell head and neck cancer
Changhu Chen, Madeleine Kane, John Song, et al.
Cancer Chemotherapy and Pharmacology
|
November 7, 2009
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas
Shivaani Kummar, Martin E Gutierrez, Erin R Gardner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 17, 2023
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Frances A Shepherd, Janet Dancey, Rodryg Ramlau, et al.
Cancer Chemotherapy and Pharmacology
|
May 22, 2010
Phase I and pharmacokinetic study of erlotinib (OSI-774) in combination with docetaxel in squamous cell carcinoma of the head and neck (SSCHN)
Eric H Kraut, Christopher Rhoades, Yilong Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study
Lillian L Siu, Denis Soulieres, Eric X Chen, et al.
Page
of 8